Latest ArticlesThe treatment of anionic 99TcO4- in the waste tank with high alkalinity is still very challenging. In this work, a new temperature-responsive alkaline aqueous biphasic system (ABS) based on (tri-n-butyl)-n-tetradecyl phosphonium chloride (P44414Cl) was developed to remove radioactive 99TcO4-. The phase transition mechanism was studied by cloud point titration, small-angel X-ray scattering, dynamic light scattering, and molecular dynamic simulations. As the NaOH concentration or temperature increased, the P44414+ micelle could grow and aggregate. This micelle showed a particularly high affinity toward ReO4-/99TcO4- compared to other competing anions and could directly extract more than 98.6% of 99TcO4- from simulated radioactive tank waste supernatant. Furthermore, the loaded 99TcO4- could be easily stripped by using concentrated nitric acid rather than metal salt-based reductants. This work clearly demonstrates that the alkaline ABS is a promising separation system for solving the technetium problem in the alkaline waste tank.
Carbohydrate antigen 19-9 (CA19-9) with multi epitopes relatively high expresses on colorectal cancer (CRC) cells, making it an attractive target for developing radioimmunotherapy (RIT) for CRC. The lutetium-177 (177Lu) labeled monoclonal antibodies (mAbs) can selectively bind the corresponding antigens and release targeted cytotoxic radiation, which could induce cell apoptosis and reduce the drug-induced resistance. Here, a series of CA19-9 mAbs were labeled with zirconium-89 (89Zr), and one with high tumor uptake was screened via PET imaging, which has potential application for the diagnosis of CRC. Then the screened mAb (C003) labeled with 177Lu was utilized for CA19-9 targeted RIT, which presents a significant suppression effect on the growth of colo205 xenografts than immunotherapy alone. Meanwhile, the side effects of 177Lu-DOTA-C003 are limited according to the results of in vivo study. Both 89Zr-DFO-C003 for CRC immune-PET imaging and 177Lu-DOTA-C003 for RIT against CRC exhibit good potential in clinical applications.
Nitrogen enrichment and increased nitrogen content is an effective strategy for enhancing adsorption of uranium by carbon nitride polymers. Herein, we reported the uranium absorption by using a structurally well-defined and nitrogen-rich carbon nitride polymer with C3N5 stoichiometry for the first time. In comparison with the adsorption performance of g-C3N4 for U(VI), the conjugation system of the material was increased by connecting the heptazine unit through the azo bridge in the structure of C3N5, so that C3N5 exhibited several times higher adsorption performance than that of g-C3N4. The C3N5 has high kinetics for uranyl ions, which can adsorb 100 mg/g U(VI) in only 10 min and reach complete adsorption equilibrium in 60 min; the theoretical maximum adsorption capacity is 207 mg/g, meanwhile, the material exhibits high selectivity. The results of spectral analysis and theoretical calculations indicate that the process of uranyl ion capture by C3N5 is a combination of physical and chemical adsorption, and its higher density of electronic states makes the electrostatic binding ability enhanced, which is favorable to the adsorption of uranyl ions by C3N5. This work indicates that C3N5 has great promise and application in the separation and enrichment of uranyl ions, and also provides a reference for the systematic investigation of the adsorption ability of nitrogen-rich carbon nitrogen polymers on uranyl ions.
The development of uranyl ion detection technology has exhibited its significance in public security and environmental fields for the radioactivity and chemical toxicity of uranyl ion. The WHO standard of uranyl ion makes it necessary to develop highly sensitive uranyl rapid warning system in drinking water monitoring. Herein, a visualized rapid warning system for trace uranyl ion is carried out based on electrochemiluminescence (ECL) imaging technology to give an ultra-low limit of detection (LOD) and high selectivity. Amidoxime, a bi-functional group with both uranyl ion capturing and co-reactive functions, is modified on a conjugated polymer backbone with strong ECL signal to be prepared into three-in-one polymer nanoparticles (PNPs) with self-enhanced ECL property. The captured uranyl ion can enhance the ECL signal of PNPs via resonance energy transfer process to give the LOD as 0.5 ng/L, which is much lower than the known luminescent uranyl sensors. Furthermore, ECL imaging technology is introduced into realizing visualized uranyl rapid warning, and can be successfully applied on natural water samples. This study provides a novel strategy for uranyl rapid warning, and shows its potential meaning in public security and environmental fields.
Phototheranostics have attracted tremendous attention in cancer diagnosis and treatment because of the noninvasiveness and promising effectiveness. Developing advanced phototheranostic agents with long emission wavelength, excellent biocompatibility, great tumor-targeting capability, and efficient therapeutic effect is highly desirable. However, the mutual constraint between imaging and therapeutic functions usually hinders their wide applications in biomedical field. To balance this contradiction, we herein rationally designed and synthesized three novel tumor-targeted NIR-II probes (QR-2PEG321, QR-2PEG1000, and QR-2PEG5000) by conjugating three different chain lengths of PEG onto an integrin αvβ3-targeted NIR-II heptamethine cyanine fluorophore, respectively. In virtue of the essential amphiphilic characteristics of PEG polymers, these probes display various degree of aggregation in aqueous buffer accompanying with differential NIR-II imaging and photothermal (PTT) therapeutic performance. Both in vitro and in vivo results have demonstrated that probe QR-2PEG5000 has the best NIR-II imaging performance with prominent renal clearance, whereas QR-2PEG321 possesses excellent photoacoustic signal as well as PTT effect, which undoubtedly provides a promising toolbox for tumor diagnosis and therapy. We thus envision that these synthesized probes have great potential to be explored as a toolkit for precise diagnosis and treatment of malignant tumors.
Two tetravalent uranium silicate and germanate M2UIVT3O9 (M = K, Cs; T = Si, Ge) crystals were crystalized under inert gas by molten salt flux growth method. K2USi3O9 (1) crystallizes in the monoclinic space group P121/n1 with lattice parameters a = 7.1076 Å, b = 10.4776 Å, c = 12.2957 Å, γ = 120° and V = 915.67 Å3. Cs2UGe3O9 (2) crystallizes in a hexagonal space group P-6 with lattice constants of a = 7.5138 Å, b = 7.5138 Å, c = 11.0114 Å, γ = 120° and V = 538.38 Å3. Bond valence calculations indicate tetravalent uranium in both structures, which contain three-membered single-ring T3O96− trimers. K2USi3O9 is the first uranium silicate that contains the Si3O96− trimers.
The prevalence of positron emission tomography (PET) imaging has advanced biomedical applications for its ultrahigh sensitivity, deep tissue penetration and quantitative visualization of diseases in vivo. 64Cu with ideal half-life and decay characteristics has been designed as radioactive probes for disease diagnosis. The currently reported 64Cu-labeled nanomaterials have the advantages of long circulation time in serum, good biocompatibility and mature preparation methods, and have been used in vivo PET imaging, biodistribution and pharmacokinetic monitoring, and imaging guided therapy. At the same time, suitable carrier characteristics and radiolabeling strategies are particularly important in the 64Cu PET imaging process. In this review, we summarize different imaging probe designs and 64Cu radiolabeling strategies, as well as their eventual applications in biomedicine. The potential challenges and prospects of 64Cu labeled nanomaterials are also described, which provides broad prospects for radiolabeling strategies and further applications.
While radiotherapy is a mainstay therapeutic modality for malignant tumor, the intrinsic tumor resistance to radiotherapy, as well as the concomitant radiation injury to adjacent healthy tissues, greatly limits the efficacy of cancer radiotherapy. As a result, the development of novel radioenhancers and radioprotectants is highly desired for clinical radiotherapy. In recent years, nanozymes have inspired ever-growing research interest because of their multi-enzyme activities and microenvironment-responsive feature. In view of the significant progress of nanozymes in radiation medicine, we, in this review, systematically illustrate the impressive progress of nanozymes for potentiating radiotherapy and radiation protection. First, the types of nanozymes used in tumor radiotherapy are briefly discussed. Subsequently, the main strategies of nanozymes to enhance the radiotherapy efficiency, including promoting the generation of reactive oxygen species (ROS), relieving hypoxia in tumor microenvironment and combining with other cancer therapeutic regimens, are summarized. Finally, the advances of typical nanozymes for preventing radiation-induced hematopoietic damage and gastrointestinal damage are highlighted.
Soft N-donor bis-triazin bipyridines derives (R-BTBP) are a type of very promising extratant for extraction and complexation with long-lived trivalent minor actinides over lanthanides from highly active liquid waste (HLW). In addition to minor actinides, R-BTBP also holds very strong complexation ability toward fission palladium. However, few studies have been focused on the separation and complexation with the fission product Pd(Ⅱ) by R-BTBP. Herein, the complexation behaviors of Pd(Ⅱ) with four typical R-BTBP ligands were systematically studied by single crystal X-ray diffraction, 1H NMR titration and theoretical calculation. The effects of R-BTBP initial conformation and nitrate anions on the complexation behaviors of R-BTBP with Pd(Ⅱ) were thoughtfully analyzed. Both the 1:1 and 2:1 binuclear complexes could be formed between Pd(Ⅱ) and R-BTBP with initial Ⅱ conformation in the presence of nitrate anions, while only one 1:1 type Pd(Ⅱ) complex could be formed for those with initial OO conformation. Without nitrate anion, only one 1:1 type complex was formed in solution. The structure of the 1:1 Pd(Ⅱ)/R-BTBP complex was firstly characterized by single crystal crystallography. DFT calculation results showed that a significant large rotational energy barrier (21.8~22.6 kcal/mol) must be overcome to form the Ⅱ type 2:1 Pd(Ⅱ) complex for those OO type R-BTBP ligands, however which would not prevent them from forming the 1:1 type complex.
The in vivo degradation behavior of metallic nanoparticles (NPs) is very important for their biomedical applications and safety evaluation. Here, a method of laser ablation-single particle inductively coupled plasma mass spectrometry (LA-sp-ICP-MS) is shown to have high spatial resolution, sensitivity and accuracy for simultaneous imaging the in situ distribution of particulate Ag (P-Ag) and released ionic Ag (Ion-Ag) in the sub-organs of spleen, liver and kidney after intravenous injection of Ag nanoparticles (50 nm, AgNPs) to mice. Under the optimized parameters of 0.4 J/cm2 laser fluence on a 30 µm spot with dwell time at 100 µs, the signals of P-Ag and Ion-Ag in the organic tissues can be easily distinguished from the mass spectra. The method of iterative threshold algorithm has been used to distract the signals of P-Ag and Ion-Ag and separate each other. The resulting images for the first time provide visualized evidence that a considerable amount of P-Ag accumulated in the splenic marginal zone, but widely distributed in the liver parenchyma at 24 h after injection of AgNPs, and in the meantime, obvious amounts of ionic Ag released and distributed in the organs. In addition, the imaging results indicate that the AgNP excretion in the kidney is mainly in ionic forms. The investigation here demonstrates that the developed LA-sp-ICP-MS method with high spatial resolution, sensitivity and visualization capability can become a powerful tool in the clinical context of metallic NPs.